Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-07-17

FDA Approved: NOVOLIN R — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA approved a supplemental application for Novo Nordisk's NOVOLIN R (human insulin).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NOVOLIN R (HUMAN INSULIN)

Snippet

SUPPL AP for NOVOLIN R (HUMAN INSULIN)